United States

Novozymes A/S (NVZMY.PK)

NVZMY.PK on OTC Markets Group

23 May 2017
Change (% chg)

$-0.22 (-0.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for NVZMY.PK


Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and... (more)


No Ratios Available.


  NVZMY.PK Industry Sector
P/E (TTM): -- 21.08 37.20
EPS (TTM): -- -- --
ROI: -- 19.23 11.67
ROE: -- 28.25 15.11

REFILE-UPDATE 1-Novozymes shares rise to 9-month high after Q1 earnings

April 26 Danish enzymes maker Novozymes posted slightly better-than-expected revenues for the first quarter on Wednesday and said it would launch a new product in the autumn, sending its shares up more than 5 percent to a nine-month high.

Apr 26 2017

BRIEF-Novozymes Q1 EBIT up at DKK 1.01 billion, in line with expectations


Apr 26 2017

Denmark's Novo A/S ups Synlab stake to 20 pct before possible IPO

COPENHAGEN, April 12 Danish life science investor Novo A/S said on Wednesday it was raising its stake in Synlab to about 20 percent through a 250 million euro ($265 million) subscription to new shares, ahead of a potential listing of Europe's second largest lab operator.

Apr 12 2017

BRIEF-Novozymes, Boehringer announce strategic collaboration in probiotics for poultry hatcheries

* Novozymes and Boehringer Ingelheim announce strategic collaboration in probiotics for poultry hatcheries

Mar 30 2017

BRIEF-Dong Energy to build biogas plant for Novo Nordisk, Novozymes residues

* Says will in cooperation with Bigadan build a large-scale biogas plant

Mar 23 2017

BRIEF-Coor Service Management Holding signs agreement with Novozymes in Denmark

* Delivery to Novozymes starts May 1 Source text: http://bit.ly/2mviZql

Mar 23 2017

BRIEF-Novozymes President and CEO buys 27,700 shares at DKK 6,997,574

* President and CEO Peder Holk Nielsen buys 27,700 shares in Novozymes at 6,997,574 Danish crowns ($1 million) Source text for Eikon:

Jan 26 2017

BRIEF-Novozymes initiates stock buyback program

* Will buy back B shares worth up to 2 billion Danish crowns ($288.9 million) in total during remainder of 2017, corresponding to around 8.1 million B shares at current share price

Jan 24 2017

BRIEF-Novozymes EVP Anders Lund sells shares at about DKK 3.6 million

* Executive Vice President Anders Lund has sold 14,477 shares in Novozymes at about 3.6 million Danish crowns ($519,691)

Jan 23 2017

Novozymes cuts jobs, says U.S. policy, Monsanto deal pose risks

COPENHAGEN Enzymes maker Novozymes will cut 198 jobs and invest more in emerging markets, it said on Wednesday, adding it could time take to recapture past growth rates amid uncertainty over U.S. renewable energy policy and the takeover of a key partner.

Jan 18 2017

More From Around the Web

Earnings vs. Estimates